{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:06:31Z","timestamp":1790003191729,"version":"4.0.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"45","license":[{"start":{"date-parts":[[2013,1,14]],"date-time":"2013-01-14T00:00:00Z","timestamp":1358121600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1038\/onc.2012.571","type":"journal-article","created":{"date-parts":[[2013,1,14]],"date-time":"2013-01-14T13:36:01Z","timestamp":1358170561000},"page":"5292-5301","source":"Crossref","is-referenced-by-count":42,"title":["Involvement of EphA2-mediated tyrosine phosphorylation of Shp2 in Shp2-regulated activation of extracellular signal-regulated kinase"],"prefix":"10.1038","volume":"32","author":[{"given":"K","family":"Miura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Wakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Tanino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Orba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Sawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Hatakeyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Sabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,14]]},"reference":[{"key":"BFonc2012571_CR1","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10555-008-9126-y","volume":"27","author":"G Chan","year":"2008","unstructured":"Chan G, Kalaitzidis D, Neel BG . The tyrosine phosphatase Shp2 (PTPN11) in cancer. Cancer Metastasis Rev 2008; 27: 179\u2013192.","journal-title":"Cancer Metastasis Rev"},{"key":"BFonc2012571_CR2","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.cellsig.2007.10.002","volume":"20","author":"M Dance","year":"2008","unstructured":"Dance M, Montagner A, Salles JP, Yart A, Raynal P . The molecular functions of Shp2 in the Ras\/mitogen-activated protein kinase (ERK1\/2) pathway. Cell Signal 2008; 20: 453\u2013459.","journal-title":"Cell Signal"},{"key":"BFonc2012571_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0065-230X(10)06002-1","volume":"106","author":"KS Grossmann","year":"2010","unstructured":"Grossmann KS, Rosario M, Birchmeier C, Birchmeier W . The tyrosine phosphatase Shp2 in development and cancer. Adv Cancer Res 2010; 106: 53\u201389.","journal-title":"Adv Cancer Res"},{"key":"BFonc2012571_CR4","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.gde.2009.04.001","volume":"19","author":"WE Tidyman","year":"2009","unstructured":"Tidyman WE, Rauen KA . The RASopathies: developmental syndromes of Ras\/MAPK pathway dysregulation. Curr Opin Genet Dev 2009; 19: 230\u2013236.","journal-title":"Curr Opin Genet Dev"},{"key":"BFonc2012571_CR5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1749-6632.2010.05790.x","volume":"1214","author":"M Tartaglia","year":"2010","unstructured":"Tartaglia M, Gelb BD . Disorders of dysregulated signal traffic through the RAS-MAPK pathway: phenotypic spectrum and molecular mechanisms. Ann NY Acad Sci 2010; 1214: 99\u2013121.","journal-title":"Ann NY Acad Sci"},{"key":"BFonc2012571_CR6","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/nature09005","volume":"465","author":"X Carvajal-Vergara","year":"2010","unstructured":"Carvajal-Vergara X, Sevilla A, D\u2019Souza SL, Ang YS, Schaniel C, Lee DF et al. Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature 2010; 465: 808\u2013812.","journal-title":"Nature"},{"key":"BFonc2012571_CR7","doi-asserted-by":"publisher","first-page":"41677","DOI":"10.1074\/jbc.M306461200","volume":"278","author":"T Araki","year":"2003","unstructured":"Araki T, Nawa H, Neel BG . Tyrosyl phosphorylation of Shp2 is required for normal ERK activation in response to some, but not all, growth factors. J Biol Chem 2003; 278: 41677\u201341684.","journal-title":"J Biol Chem"},{"key":"BFonc2012571_CR8","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S1097-2765(00)80287-7","volume":"2","author":"V Cleghon","year":"1998","unstructured":"Cleghon V, Feldmann P, Ghiglione C, Copeland TD, Perrimon N, Hughes DA et al. Opposing actions of CSW and RasGAP modulate the strength of torso RTK signaling in the Drosophila terminal pathway. Mol Cell 1998; 2: 719\u2013727.","journal-title":"Mol Cell"},{"key":"BFonc2012571_CR9","doi-asserted-by":"publisher","first-page":"4241","DOI":"10.1016\/j.febslet.2010.09.016","volume":"584","author":"Y Cha","year":"2010","unstructured":"Cha Y, Park KS . SHP2 is a downstream target of ZAP70 to regulate JAK1\/STAT3 and ERK signaling pathways in mouse embryonic stem cells. FEBS Lett 2010; 584: 4241\u20134246.","journal-title":"FEBS Lett"},{"key":"BFonc2012571_CR10","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.cell.2010.06.011","volume":"141","author":"MA Lemmon","year":"2010","unstructured":"Lemmon MA, Schlessinger J . Cell signaling by receptor tyrosine kinases. Cell 2010; 141: 1117\u20131134.","journal-title":"Cell"},{"key":"BFonc2012571_CR11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2174\/1568009053765780","volume":"5","author":"RC Ireton","year":"2005","unstructured":"Ireton RC, Chen J . EphA2 receptor tyrosine kinase as a promising target for cancer therapeutics. Curr Cancer Drug Targets 2005; 5: 149\u2013157.","journal-title":"Curr Cancer Drug Targets"},{"key":"BFonc2012571_CR12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1172\/JCI33154","volume":"118","author":"DM Brantley-Sieders","year":"2008","unstructured":"Brantley-Sieders DM, Zhuang G, Hicks D, Fang WB, Hwang Y, Cates JM et al. The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling. J Clin Invest 2008; 118: 64\u201378.","journal-title":"J Clin Invest"},{"key":"BFonc2012571_CR13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cell.2008.03.011","volume":"133","author":"EB Pasquale","year":"2008","unstructured":"Pasquale EB . Eph-ephrin bidirectional signaling in physiology and disease. Cell 2008; 133: 38\u201352.","journal-title":"Cell"},{"key":"BFonc2012571_CR14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/nrc2806","volume":"10","author":"EB Pasquale","year":"2010","unstructured":"Pasquale EB . Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nat Rev Cancer 2010; 10: 165\u2013180.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2012571_CR15","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1007\/s00018-007-6509-0","volume":"64","author":"T Edouard","year":"2007","unstructured":"Edouard T, Montagner A, Dance M, Conte F, Yart A, Parfait B et al. How do Shp2 mutations that oppositely influence its biochemical activity result in syndromes with overlapping symptoms? Cell Mol Life Sci 2007; 64: 1585\u20131590.","journal-title":"Cell Mol Life Sci"},{"key":"BFonc2012571_CR16","doi-asserted-by":"publisher","first-page":"13842","DOI":"10.1074\/jbc.275.18.13842","volume":"275","author":"JM Cunnick","year":"2000","unstructured":"Cunnick JM, Dorsey JF, Munoz-Antonia T, Mei L, Wu J . Requirement of SHP2 binding to Grb2-associated binder-1 for mitogen-activated protein kinase activation in response to lysophosphatidic acid and epidermal growth factor. J Biol Chem 2000; 275: 13842\u201313848.","journal-title":"J Biol Chem"},{"key":"BFonc2012571_CR17","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/S0006-291X(02)00806-9","volume":"296","author":"Y Wang","year":"2002","unstructured":"Wang Y, Ota S, Kataoka H, Kanamori M, Li Z, Band H et al. Negative regulation of EphA2 receptor by Cbl. Biochem Biophys Res Commun 2002; 296: 214\u2013220.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFonc2012571_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ccr.2009.04.009","volume":"16","author":"H Miao","year":"2009","unstructured":"Miao H, Li DQ, Mukherjee A, Guo H, Petty A, Cutter J et al. EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt. Cancer Cell 2009; 16: 9\u201320.","journal-title":"Cancer Cell"},{"key":"BFonc2012571_CR19","doi-asserted-by":"publisher","first-page":"16017","DOI":"10.1074\/jbc.M709934200","volume":"283","author":"WB Fang","year":"2008","unstructured":"Fang WB, Brantley-Sieders DM, Hwang Y, Ham AJ, Chen J . Identification and functional analysis of phosphorylated tyrosine residues within EphA2 receptor tyrosine kinase. J Biol Chem 2008; 283: 16017\u201316026.","journal-title":"J Biol Chem"},{"key":"BFonc2012571_CR20","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.ctrv.2010.02.015","volume":"36","author":"J Araujo","year":"2010","unstructured":"Araujo J, Logothetis C . Dasatinib: a potent SRC inhibitor in clinical development for the treatment of solid tumors. Cancer Treat Rev 2010; 36: 492\u2013500.","journal-title":"Cancer Treat Rev"},{"key":"BFonc2012571_CR21","doi-asserted-by":"publisher","first-page":"e225","DOI":"10.1371\/journal.pgen.0030225","volume":"3","author":"C Jopling","year":"2007","unstructured":"Jopling C, van Geemen D, den Hertog J . Shp2 knockdown and Noonan\/LEOPARD mutant Shp2-induced gastrulation defects. PLoS Genet 2007; 3: e225.","journal-title":"PLoS Genet"},{"key":"BFonc2012571_CR22","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.devcel.2010.03.009","volume":"18","author":"RA Stewart","year":"2010","unstructured":"Stewart RA, Sanda T, Widlund HR, Zhu S, Swanson KD, Hurley AD et al. Phosphatase-dependent and -independent functions of Shp2 in neural crest cells underlie LEOPARD syndrome pathogenesis. Dev Cell 2010; 18: 750\u2013762.","journal-title":"Dev Cell"},{"key":"BFonc2012571_CR23","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1074\/mcp.M600482-MCP200","volume":"6","author":"S Lemeer","year":"2007","unstructured":"Lemeer S, Ruijtenbeek R, Pinkse MW, Jopling C, Heck AJ, den Hertog J et al. Endogenous phosphotyrosine signaling in zebrafish embryos. Mol Cell Proteomics 2007; 6: 2088\u20132099.","journal-title":"Mol Cell Proteomics"},{"key":"BFonc2012571_CR24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ccr.2005.07.005","volume":"8","author":"M Macrae","year":"2005","unstructured":"Macrae M, Neve RM, Rodriguez-Viciana P, Haqq C, Yeh J, Chen C et al. A conditional feedback loop regulates Ras activity through EphA2. Cancer Cell 2005; 8: 111\u2013118.","journal-title":"Cancer Cell"},{"key":"BFonc2012571_CR25","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/ncb867","volume":"4","author":"H Hanafusa","year":"2002","unstructured":"Hanafusa H, Torii S, Yasunaga T, Nishida E . Sprouty1 and Sprouty2 provide a control mechanism for the Ras\/MAPK signalling pathway. Nat Cell Biol 2002; 4: 850\u2013858.","journal-title":"Nat Cell Biol"},{"key":"BFonc2012571_CR26","doi-asserted-by":"publisher","first-page":"7875","DOI":"10.1128\/MCB.23.21.7875-7886.2003","volume":"23","author":"YM Agazie","year":"2003","unstructured":"Agazie YM, Hayman MJ . Molecular mechanism for a role of SHP2 in epidermal growth factor receptor signaling. Mol Cell Biol 2003; 23: 7875\u20137886.","journal-title":"Mol Cell Biol"},{"key":"BFonc2012571_CR27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1083\/jcb.200205017","volume":"159","author":"T Cai","year":"2002","unstructured":"Cai T, Nishida K, Hirano T, Khavari PA . Gab1 and SHP-2 promote Ras\/MAPK regulation of epidermal growth and differentiation. J Cell Biol 2002; 159: 103\u2013112.","journal-title":"J Cell Biol"},{"key":"BFonc2012571_CR28","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S1097-2765(01)00369-0","volume":"8","author":"W Lu","year":"2001","unstructured":"Lu W, Gong D, Bar-Sagi D, Cole PA . Site-specific incorporation of a phosphotyrosine mimetic reveals a role for tyrosine phosphorylation of SHP-2 in cell signaling. Mol Cell 2001; 8: 759\u2013769.","journal-title":"Mol Cell"},{"key":"BFonc2012571_CR29","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S0968-0004(03)00091-4","volume":"28","author":"BG Neel","year":"2003","unstructured":"Neel BG, Gu H, Pao L . The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem Sci 2003; 28: 284\u2013293.","journal-title":"Trends Biochem Sci"},{"key":"BFonc2012571_CR30","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1126\/science.1067147","volume":"295","author":"H Higashi","year":"2002","unstructured":"Higashi H, Tsutsumi R, Muto S, Sugiyama T, Azuma T, Asaka M et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 2002; 295: 683\u2013686.","journal-title":"Science"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/onc2012571.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/onc2012571","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/onc2012571.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:57:04Z","timestamp":1684472224000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2012571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,14]]},"references-count":30,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["BFonc2012571"],"URL":"https:\/\/doi.org\/10.1038\/onc.2012.571","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,14]]}}}